Lower Carbohydrate Diets and All-cause and Cause-specific Mortality: a Population-based Cohort Study and Pooling of Prospective Studies
Overview
Affiliations
Aims: Little is known about the long-term association between low-carbohydrate diets (LCDs) and mortality. We evaluated the link between LCD and overall or cause-specific mortality using both individual data and pooled prospective studies.
Methods And Results: Data on diets from the National Health and Nutrition Examination Survey (NHANES; 1999-2010) were analysed. Multivariable Cox proportional hazards were applied to determine the hazard ratios and 95% confidence intervals (CIs) for mortality for each quartile of the LCD score, with the lowest quartile (Q1-with the highest carbohydrates intake) used as reference. We used adjusted Cox regression to determine the risk ratio (RR) and 95% CI, as well as random effects models and generic inverse variance methods to synthesize quantitative and pooled data, followed by a leave-one-out method for sensitivity analysis. Overall, 24 825 participants from NHANES study were included (mean follow-up 6.4 years). After adjustment, participants with the lowest carbohydrates intake (quartile 4 of LCD) had the highest risk of overall (32%), cardiovascular disease (CVD) (50%), cerebrovascular (51%), and cancer (36%) mortality. In the same model, the association between LCD and overall mortality was stronger in the non-obese (48%) than in the obese (19%) participants. Findings on pooled data of nine prospective cohort studies with 462 934 participants (mean follow-up 16.1 years) indicated a positive association between LCD and overall (RR 1.22, 95% CI 1.06-1.39, P < 0.001, I2 = 8.6), CVD (RR 1.13, 95% CI 1.02-1.24, P < 0.001, I2 = 11.2), and cancer mortality (RR 1.08, 95% CI 1.01-1.14, P = 0.02, I2 = 10.3). These findings were robust in sensitivity analyses.
Conclusion: Our study suggests a potentially unfavourable association of LCD with overall and cause-specific mortality, based on both new analyses of an established cohort and by pooling previous cohort studies. Given the nature of the study, causality cannot be proven; we cannot rule out residual bias. Nevertheless, further studies are needed to extend these important findings, which if confirmed, may suggest a need to rethink recommendations for LCD in clinical practice.
Thakur B, Malaise Y, Choudhury S, Neustaeter A, Turpin W, Streutker C Nat Microbiol. 2025; .
PMID: 40033140 DOI: 10.1038/s41564-025-01938-4.
Zhang X, Mo J, Yang K, Tan T, Zhao C, Qin H Front Nutr. 2025; 11():1519782.
PMID: 39777077 PMC: 11706202. DOI: 10.3389/fnut.2024.1519782.
Ketogenic diet in clinical populations-a narrative review.
Zemer A, Samaei S, Yoel U, Biderman A, Pincu Y Front Med (Lausanne). 2024; 11:1432717.
PMID: 39534224 PMC: 11554467. DOI: 10.3389/fmed.2024.1432717.
Zhao M, Zhang Q, Lin Y, Zhang D, Cao H PLoS One. 2024; 19(10):e0310184.
PMID: 39413081 PMC: 11482686. DOI: 10.1371/journal.pone.0310184.
Azevedo L, Martins H, Luft V, da Fonseca M, Enriquez-Martinez O, Molina M Nutrients. 2024; 16(16).
PMID: 39203817 PMC: 11357444. DOI: 10.3390/nu16162680.